Dr. Larry W. Moreland presents on rheumatoid and psoriatic arthritis and focuses on the names of biologics and targets in the immune system. Dr. Moreland reviews the guidelines for monitoring and prevention of side effects associated with therapies for treating rheumatoid and psoriatic arthritis.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- Identify the general adverse effects of targeted immunotherapy for rheumatoid arthritis and psoriatic arthritis
- Explain the names and biologic targets of immune system of various biological agents used to treat rheumatoid arthritis and psoriatic arthritis
- Recall the accepted guidelines for monitoring and prevention of potential adverse events associated with therapies for rheumatoid arthritis and psoriatic arthritis
Disclosures:
Dr. Larry W. Moreland has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Grant/Research Support: Bristol Myers Squibb, Genentech, Mallinckrodt, Pfizer, Roche
- Consultant: Boeinger Ingelheim - DSMB, Pfizer - DSMB, Xencor - DSMB
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to .75 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
ABIM MOC Part 2 Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive your ABIM MOC Part 2 credit, you will need to complete the post-test with a pass rate of 100% and provide your date of birth and ABIM number, along with the other required fields. This information will be shared with the American Board of Internal Medicine using the Accreditation Council for Continuing Medical Education Program and Activity Reporting System.
Release Date: 2/12/2019 | Last Modified On: 2/12/2019 | Expires: 2/12/2020
